VERACYTE, INC. (VCYT)

↓ Download CSV

CIK 0001384101 · Nasdaq · Services-Medical Laboratories

  • Sector Services
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, VERACYTE, INC. reported revenue of $517.14M, up 16.0% from the prior year. The company was profitable, with a net margin of 12.8% and a gross margin of 70.1%. It held $1.41B in total assets against $96.44M in total liabilities.

Key ratios (FY2025)

70.1%
Gross margin
11.2%
Operating margin
12.8%
Net margin
5.1%
Return on equity
+16.0%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$517.14M$445.76M$361.05M$296.54M$219.51M$117.48M$120.37M$92.01M$71.95M$65.08M
Cost of Revenue$36.08M$33.08M$28.20M$25.46M
Gross Profit$362.53M$298.14M$229.68M$175.68M
Operating Income$57.78M$16.14M-$85.80M-$41.08M-$81.90M-$35.39M-$15.13M-$22.23M-$26.54M-$28.80M
Net Income$66.35M$24.14M-$74.40M-$36.56M-$75.56M-$34.91M-$12.60M-$23.00M
EPS (Diluted)$0.82$0.31$-1.02$-0.51$-1.11$-0.66$-0.27
Total Assets$1.41B$1.30B$1.11B$1.16B$1.19B$457.16M$275.21M$120.64M$78.67M$101.03M
Total Liabilities$96.44M$124.07M$70.80M$81.22M$91.31M$35.93M$35.76M$40.88M$41.44M$41.45M
Shareholders' Equity$1.31B$1.18B$1.04B$1.08B$1.10B$421.23M$239.46M$79.75M$37.23M$59.58M
Cash & Equivalents$362.58M$239.09M$216.45M$154.25M$173.20M$349.36M$159.32M$78.00M$33.89M$59.22M
Operating Cash Flow$136.31M$75.10M$44.22M$7.54M-$31.62M-$9.71M-$3.23M-$13.52M-$23.91M-$27.98M
Capital Expenditures$9.68M$11.29M$9.96M$8.55M$5.38M$2.84M$2.76M$1.87M$1.75M$4.21M
Shares Outstanding79.36M77.77M73.26M71.96M71.12M58.20M49.63M40.86M33.76M33.76M